Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
Gemma Conte(Dompé (Italy)), Francesca Ungaro(University of Naples Federico II), Agnese Miro(University of Naples Federico II), Olivia M. Merkel(Ludwig-Maximilians-Universität München), Paola Brocca(University of Milan), Gabriella Costabile(Ludwig-Maximilians-Universität München), Rosaria Bassi(University of Milan), Valeria Rondelli(University of Milan), Giulia Linardos(Bambino Gesù Children's Hospital), Ivana d’Angelo(University of Campania "Luigi Vanvitelli"), Domizia Baldassi(Ludwig-Maximilians-Universität München), Raffaella Sorrentino(University of Naples Federico II), Ersilia Fiscarelli(Bambino Gesù Children's Hospital), Diego Colombo(University of Milan), Fabiana Quaglia(University of Naples Federico II)
Cited by 96
Related Papers
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
|Bioengineering & Translational Medicine|2021|352
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
|Nature Communications|2016|232
Lipids and polymers in pharmaceutical technology: Lifelong companions
|International Journal of Pharmaceutics|2019|146
Mannose and Mannose‐6‐Phosphate Receptor–Targeted Drug Delivery Systems and Their Application in Cancer Therapy
|Advanced Healthcare Materials|2018|132
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis
|Nature Communications|2017|129